Cite
HARVARD Citation
Pfisterer, J. et al. (2020). Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial. Lancet oncology. 21 (5), pp. 699-709. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pfisterer, J. et al. (2020). Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial. Lancet oncology. 21 (5), pp. 699-709. [Online].